Home Cart 0 Sign in  
X

[ CAS No. 118-41-2 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 118-41-2
Chemical Structure| 118-41-2
Chemical Structure| 118-41-2
Structure of 118-41-2 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 118-41-2 ]

Related Doc. of [ 118-41-2 ]

Alternatived Products of [ 118-41-2 ]

Product Details of [ 118-41-2 ]

CAS No. :118-41-2 MDL No. :MFCD00002501
Formula : C10H12O5 Boiling Point : -
Linear Structure Formula :- InChI Key :SJSOFNCYXJUNBT-UHFFFAOYSA-N
M.W : 212.20 Pubchem ID :8357
Synonyms :
Eudesmic acid;Trimethylgallic Acid;TMBA;NSC 2525;Gallic acid trimethyl ether

Calculated chemistry of [ 118-41-2 ]

Physicochemical Properties

Num. heavy atoms : 15
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.3
Num. rotatable bonds : 4
Num. H-bond acceptors : 5.0
Num. H-bond donors : 1.0
Molar Refractivity : 52.88
TPSA : 64.99 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.56 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.85
Log Po/w (XLOGP3) : 1.45
Log Po/w (WLOGP) : 1.41
Log Po/w (MLOGP) : 0.8
Log Po/w (SILICOS-IT) : 1.28
Consensus Log Po/w : 1.36

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -2.1
Solubility : 1.68 mg/ml ; 0.00792 mol/l
Class : Soluble
Log S (Ali) : -2.42
Solubility : 0.806 mg/ml ; 0.0038 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.16
Solubility : 1.46 mg/ml ; 0.0069 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.83

Safety of [ 118-41-2 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 118-41-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 118-41-2 ]
  • Downstream synthetic route of [ 118-41-2 ]

[ 118-41-2 ] Synthesis Path-Upstream   1~12

  • 1
  • [ 88775-41-1 ]
  • [ 3162-29-6 ]
  • [ 88775-49-9 ]
  • [ 88775-29-5 ]
  • [ 118-41-2 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1983, vol. 31, # 9, p. 3039 - 3055
[2] Chemical and Pharmaceutical Bulletin, 1983, vol. 31, # 9, p. 3039 - 3055
[3] Chemical and Pharmaceutical Bulletin, 1983, vol. 31, # 9, p. 3039 - 3055
  • 2
  • [ 118-41-2 ]
  • [ 4521-61-3 ]
YieldReaction ConditionsOperation in experiment
100% With thionyl chloride In chloroform for 4 h; Reflux To a mixture of 3,4,5-trimethoxybenzoic acid (8.00 g, 37.7 mmol) in CHCl3 (30 mL) was added thionyl chloride (13.7 mL, 189 mmol) in a dropwise fashion. Once the addition was completed, the reaction mixture was heated to reflux for 4 h before being cooled back to room temperature. The solvent and excess thionyl chloride was removed under reduced pressure to yield the acyl chloride 20 in quantitative yield as a colourless oil, which was subsequently used without further purification: νmax/cm-1 (NaCl) 2970, 2944, 1750, 1590, 1457, 1415, 1130, 1128.
100% With thionyl chloride In CH2C3 for 3 h; Reflux A mixture of acid 29 (3.0 g, 14.1 mmol) and thionyl chloride (4.1 mL, 56.5 mmol) in dichloromethane (25 mL) was refluxed for 3 h. The pale yellow solution was concentrated in vacuo to give the crude acid chloride 7453 (3.26 g, quant.) as a yellow pale solid. 1H NMR (CDCl3, 400 MHz) δ (ppm) 3.93 (s, 6H, 2OCH3), 3.96 (s, 3H, OCH3), 7.27 (s, 2H, ArH).
100% With thionyl chloride In dichloromethane for 3 h; Reflux To a mixture of benzoic acid 3,4,5-trimethoxybenzoic acid (2.0 g, 9.43 mmol, 1.0 eq.) and SOCl2 (4.48 g, 37.70 mmol, 4.0 eq.) in anhydrous dichloromethane (10 mL), After refluxing for 3h, the reaction mixture was concentrated in vacuo to afford compound 2a (2.2 g, 100percent) as white solid.
90% With thionyl chloride; sodium hydroxide In water; benzeneReflux 1)
Synthesis of 3,4,5-trimethoxybenzoyl chloride.
In 100 ml one necked flask equipped with reflux condenser and gas outlet tube placed in NaOH solution, 20 g (94 mmol) of 3,4,5-trimethoxybenzoic acid and 45 ml of abs. benzene are placed.
Then 0.5 ml of DMFA and 10.8 ml (150 mmol) of thionyl chloride are added.
After the end of gas evolution the mixture is refluxed for 2 h.
The solution is cooled down to 20° C., poured into the glass with 50 ml of hexane.
The precipitated white crystals of the product are filtered off.
The filtrate is evaporated in vacuum up to 1/3 of the initial volume at 50° C.
The second portion of the product is separated upon cooling down, it is filtered off and combined with the first one.
The product is dried in vacuum at 50÷60° C. for 1 h.
Yield of 3,4,5-trimethoxybenzoyl chloride-19.6 g (90percent), m. p. 77° C.

Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 22, p. 5864 - 5869
[2] Tetrahedron, 2011, vol. 67, # 25, p. 4601 - 4611
[3] Bioorganic and Medicinal Chemistry, 2011, vol. 19, # 20, p. 6042 - 6054
[4] Letters in Drug Design and Discovery, 2018, vol. 15, # 12, p. 1319 - 1328
[5] Bulletin of the Chemical Society of Japan, 2012, vol. 85, # 2, p. 236 - 244
[6] Journal of the Chemical Society, Chemical Communications, 1987, p. 1549 - 1550
[7] Bulletin de la Societe Chimique de France, 1993, vol. 130, p. 554 - 561
[8] Patent: US2013/267707, 2013, A1, . Location in patent: Paragraph 0061; 0062; 0063
[9] Bioorganic and Medicinal Chemistry, 2011, vol. 19, # 11, p. 3579 - 3584
[10] Journal of the American Chemical Society, 1949, vol. 71, p. 3657
[11] Journal of the Chemical Society, 1906, vol. 89, p. 1655
[12] Chemische Berichte, 1906, vol. 39, p. 4023
[13] Acta Phytochimica, 1934, vol. 8, p. 65,81
[14] Journal of the Chemical Society, 1925, vol. 127, p. 1635
[15] Tetrahedron, 1987, vol. 43, # 19, p. 4321 - 4328
[16] Bulletin of the Academy of Sciences of the USSR, Division of Chemical Science (English Translation), 1972, vol. 21, p. 558 - 560[17] Izvestiya Akademii Nauk SSSR, Seriya Khimicheskaya, 1972, vol. 21, p. 599 - 601
[18] Chemistry of Heterocyclic Compounds (New York, NY, United States), 1983, p. 40 - 42[19] Khimiya Geterotsiklicheskikh Soedinenii, 1983, vol. 19, # 1, p. 46 - 48
[20] Chemical and Pharmaceutical Bulletin, 1980, vol. 28, # 7, p. 2045 - 2051
[21] Chemical and Pharmaceutical Bulletin, 1992, vol. 40, # 1, p. 202 - 211
[22] Recueil: Journal of the Royal Netherlands Chemical Society, 1981, vol. 100, # 1, p. 21 - 24
[23] Journal of Organometallic Chemistry, 1982, vol. 233, # 2, p. 267 - 274
[24] Synthesis, 1994, # 3, p. 270 - 272
[25] European Journal of Medicinal Chemistry, 1994, vol. 29, # 11, p. 841 - 854
[26] Journal of Medicinal Chemistry, 1995, vol. 38, # 12, p. 2130 - 2137
[27] Journal of Medicinal Chemistry, 1997, vol. 40, # 13, p. 2035 - 2039
[28] Tetrahedron, 2000, vol. 56, # 13, p. 1837 - 1850
[29] Farmaco, 1999, vol. 54, # 8, p. 524 - 532
[30] Farmaco, 2000, vol. 55, # 6-7, p. 439 - 447
[31] Tetrahedron, 2000, vol. 56, # 51, p. 9875 - 9883
[32] Tetrahedron, 2001, vol. 57, # 25, p. 5403 - 5411
[33] Bioorganic and Medicinal Chemistry Letters, 2001, vol. 11, # 4, p. 549 - 551
[34] Journal of Chemical Research, 2005, # 2, p. 94 - 95
[35] Synthesis, 2005, # 15, p. 2521 - 2526
[36] Bioorganic and Medicinal Chemistry, 2006, vol. 14, # 5, p. 1287 - 1293
[37] Journal of Medicinal Chemistry, 2005, vol. 48, # 23, p. 7426 - 7436
[38] Bioorganic and Medicinal Chemistry, 2006, vol. 14, # 24, p. 8286 - 8294
[39] Molecules, 2007, vol. 12, # 2, p. 271 - 282
[40] Journal of Medicinal Chemistry, 2007, vol. 50, # 4, p. 599 - 602
[41] Journal of Medicinal Chemistry, 2006, vol. 49, # 25, p. 7540 - 7544
[42] Journal of the American Chemical Society, 2001, vol. 123, # 20, p. 4849 - 4850
[43] Heterocyclic Communications, 2006, vol. 12, # 6, p. 427 - 430
[44] Patent: WO2004/58705, 2004, A2, . Location in patent: Page 43-44; 50; 52-53
[45] Patent: WO2006/6178, 2006, A1, . Location in patent: Page/Page column 21
[46] Patent: US5332735, 1994, A,
[47] Journal of Medicinal Chemistry, 2008, vol. 51, # 7, p. 2018 - 2026
[48] Archiv der Pharmazie, 2007, vol. 340, # 12, p. 650 - 655
[49] Tetrahedron, 2008, vol. 64, # 49, p. 11020 - 11027
[50] Molecules, 2009, vol. 14, # 2, p. 868 - 883
[51] Bioorganic and Medicinal Chemistry, 2009, vol. 17, # 8, p. 3053 - 3060
[52] Journal of Medicinal Chemistry, 2009, vol. 52, # 3, p. 807 - 817
[53] Bioorganic and Medicinal Chemistry, 2009, vol. 17, # 14, p. 4943 - 4954
[54] Patent: EP1553075, 2005, A1, . Location in patent: Page/Page column 109
[55] Patent: US2005/214287, 2005, A1, . Location in patent: Page/Page column 46
[56] Molecules, 2009, vol. 14, # 9, p. 3313 - 3338
[57] Journal of Fluorine Chemistry, 2009, vol. 130, # 11, p. 1028 - 1034
[58] Journal of Medicinal Chemistry, 2010, vol. 53, # 4, p. 1755 - 1762
[59] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 14, p. 4132 - 4134
[60] European Journal of Medicinal Chemistry, 2010, vol. 45, # 9, p. 3870 - 3884
[61] Patent: EP1695955, 2006, A1, . Location in patent: Page/Page column 39-40
[62] Patent: WO2008/28617, 2008, A1, . Location in patent: Page/Page column 56-57
[63] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 18, p. 5469 - 5471
[64] Letters in Drug Design and Discovery, 2010, vol. 7, # 4, p. 265 - 268
[65] Journal of Natural Products, 2010, vol. 73, # 11, p. 1796 - 1802
[66] Synthesis, 2011, # 8, p. 1249 - 1254
[67] European Journal of Medicinal Chemistry, 2011, vol. 46, # 8, p. 3526 - 3530
[68] Bioorganic and Medicinal Chemistry, 2011, vol. 19, # 22, p. 6808 - 6817
[69] Journal of Medicinal Chemistry, 2011, vol. 54, # 23, p. 8188 - 8194
[70] Journal of Medicinal Chemistry, 2012, vol. 55, # 4, p. 1559 - 1571
[71] Steroids, 2012, vol. 77, # 8-9, p. 878 - 886
[72] European Journal of Medicinal Chemistry, 2012, vol. 51, p. 184 - 192
[73] Letters in Drug Design and Discovery, 2012, vol. 9, # 8, p. 780 - 788,9
[74] Journal of Chemical Crystallography, 2013, vol. 43, # 1, p. 51 - 57
[75] Organic Preparations and Procedures International, 2013, vol. 45, # 4, p. 321 - 324
[76] Molecules, 2013, vol. 18, # 7, p. 8319 - 8341
[77] European Journal of Medicinal Chemistry, 2013, vol. 68, p. 463 - 472
[78] Angewandte Chemie - International Edition, 2013, vol. 52, # 49, p. 13086 - 13090[79] Angew. Chem., 2013, vol. 125, # 49, p. 13324 - 13328,5
[80] Medicinal Chemistry Research, 2014, vol. 23, # 1, p. 87 - 106
[81] Bioorganic and Medicinal Chemistry, 2014, vol. 22, # 5, p. 1529 - 1538
[82] Journal of the Chemical Society of Pakistan, 2013, vol. 35, # 2, p. 449 - 455
[83] RSC Advances, 2016, vol. 6, # 46, p. 40238 - 40249
[84] Tetrahedron, 2014, vol. 70, # 34, p. 5100 - 5108
[85] Tetrahedron, 2014, vol. 70, # 34, p. 5100 - 5108
[86] European Journal of Medicinal Chemistry, 2014, vol. 87, p. 398 - 412
[87] Angewandte Chemie - International Edition, 2014, vol. 53, # 48, p. 13115 - 13120[88] Angew. Chem., 2014, vol. 126, # 48, p. 13331 - 13336,6
[89] European Journal of Organic Chemistry, 2015, vol. 2015, # 1, p. 86 - 90
[90] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 4, p. 735 - 741
[91] Phytochemistry, 2017, vol. 143, p. 160 - 169
[92] Archiv der Pharmazie, 2015, vol. 348, # 2, p. 89 - 99
[93] Letters in Drug Design and Discovery, 2015, vol. 12, # 1, p. 20 - 28
[94] European Journal of Medicinal Chemistry, 2015, vol. 90, p. 889 - 896
[95] European Journal of Medicinal Chemistry, 2015, vol. 99, p. 125 - 137
[96] European Journal of Medicinal Chemistry, 2015, vol. 101, p. 41 - 51
[97] Letters in Drug Design and Discovery, 2015, vol. 12, # 6, p. 488 - 494
[98] Dyes and Pigments, 2015, vol. 119, p. 108 - 115
[99] Asian Journal of Chemistry, 2015, vol. 27, # 6, p. 2245 - 2248
[100] Organic and Biomolecular Chemistry, 2016, vol. 14, # 4, p. 1338 - 1358
[101] Advanced Synthesis and Catalysis, 2016, vol. 358, # 5, p. 746 - 751
[102] European Journal of Pharmaceutical Sciences, 2016, vol. 92, p. 203 - 211
[103] Chemical and Pharmaceutical Bulletin, 2016, vol. 64, # 8, p. 1136 - 1141
[104] Tetrahedron, 2016, vol. 72, # 47, p. 7496 - 7504
[105] Chemical Biology and Drug Design, 2016, vol. 88, # 6, p. 820 - 831
[106] Chemical Biology and Drug Design, 2017, vol. 89, # 3, p. 443 - 455
[107] European Journal of Medicinal Chemistry, 2017, vol. 131, p. 107 - 125
[108] Patent: CN104072425, 2016, B, . Location in patent: Paragraph 0069-0070
[109] Journal of Organic Chemistry, 2017, vol. 82, # 10, p. 5046 - 5067
[110] ChemMedChem, 2017, vol. 12, # 16, p. 1380 - 1389
  • 3
  • [ 10026-13-8 ]
  • [ 118-41-2 ]
  • [ 4521-61-3 ]
Reference: [1] Journal of the Chemical Society, 1906, vol. 89, p. 1655
  • 4
  • [ 75-15-0 ]
  • [ 10026-13-8 ]
  • [ 118-41-2 ]
  • [ 4521-61-3 ]
Reference: [1] Chemische Berichte, 1906, vol. 39, p. 4023
  • 5
  • [ 10026-13-8 ]
  • [ 118-41-2 ]
  • [ 71-43-2 ]
  • [ 4521-61-3 ]
Reference: [1] Justus Liebigs Annalen der Chemie, 1905, vol. 340, p. 230
  • 6
  • [ 118-41-2 ]
  • [ 24313-88-0 ]
Reference: [1] Angewandte Chemie, 1932, vol. 45, p. 536
[2] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 22, p. 5864 - 5869
[3] Chemistry of Heterocyclic Compounds (New York, NY, United States), 1983, p. 40 - 42[4] Khimiya Geterotsiklicheskikh Soedinenii, 1983, vol. 19, # 1, p. 46 - 48
[5] Justus Liebigs Annalen der Chemie, 1905, vol. 340, p. 230
[6] Chemische Berichte, 1959, vol. 92, p. 862,866
[7] Journal of Pharmaceutical Sciences, 1973, vol. 62, # 8, p. 1392 - 1394
[8] Organic Preparations and Procedures International, 2013, vol. 45, # 4, p. 321 - 324
[9] PLoS ONE, 2015, vol. 10, # 6,
[10] Patent: WO2012/92880, 2012, A1,
  • 7
  • [ 124012-42-6 ]
  • [ 3086-62-2 ]
  • [ 66335-38-4 ]
  • [ 118-41-2 ]
  • [ 69260-71-5 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1992, vol. 40, # 9, p. 2568 - 2571
  • 8
  • [ 118-41-2 ]
  • [ 25245-29-8 ]
Reference: [1] Tetrahedron, 1987, vol. 43, # 19, p. 4321 - 4328
  • 9
  • [ 118-41-2 ]
  • [ 6443-69-2 ]
Reference: [1] Magnetic Resonance in Chemistry, 1987, vol. 25, p. 824 - 828
[2] Justus Liebigs Annalen der Chemie, 1972, vol. 763, p. 109 - 120
[3] Justus Liebigs Annalen der Chemie, 1972, vol. 763, p. 109 - 120
  • 10
  • [ 118-41-2 ]
  • [ 2675-79-8 ]
Reference: [1] Tetrahedron Letters, 1985, vol. 26, # 48, p. 5939 - 5942
  • 11
  • [ 118-41-2 ]
  • [ 21852-50-6 ]
Reference: [1] Asian Journal of Chemistry, 2014, vol. 26, # 7, p. 2092 - 2098
  • 12
  • [ 118-41-2 ]
  • [ 554-92-7 ]
Reference: [1] Organic Process Research and Development, 2013, vol. 17, # 7, p. 981 - 984
Same Skeleton Products
Historical Records